Treatment of bacterial vaginosis with metronidazole or pivampicillin.

Abstract

In a double-blind randomized controlled trial from general practice, we assessed the efficacy of treatment with either metronidazole or pivampicillin in patients fulfilling the diagnostic criteria of bacterial vaginosis. 50 women were treated with metronidazole 500 mg twice daily and 54 with pivampicillin 700 mg twice daily, both for seven days. Evaluated four weeks after the start of treatment, we found a significantly higher cure rate in the metronidazole group (90%) than in the pivampicillin group (69%) (p = 0.01). Cure was defined as lack of fulfillment of the diagnostic criteria of bacterial vaginosis. Test for confounding according to parity and complaint of vaginal discharge showed no influence. Side-effects were significantly commoner in the pivampicillin group (28%) than in the metronidazole group (8%). We consider that metronidazole is a potent drug in the treatment of bacterial vaginosis, with pivampicillin as a useful alternative.

• Authors: H Schmidt, J G Hansen
• Journal: Scandinavian journal of primary health care (Scand J Prim Health Care) Vol. 9 Issue 3 Pg. 197-202 (Sep 1991) ISSN: 0281-3432 [Print] United States
• PMID: 1754753 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)

Chemical References

• Pivampicillin
• Metronidazole

Topics

• Adolescent
• Adult
• Data Interpretation, Statistical
• Double-Blind Method
• Family Practice
• Female
• Follow-Up Studies
• Humans
• Metronidazole (therapeutic use)
• Middle Aged
• Pivampicillin (therapeutic use)
• Vaginosis, Bacterial (drug therapy)